Karyopharm Therapeutics Inc. License Agreements
4 Contracts & Agreements
- License Agreement, dated as of December 17, 2021, between the Registrant and Berlin-Chemie AG (Menarini Group) (Filed With SEC on March 1, 2022)
- Amendment to License Agreement, dated May 1, 2020, by and between Antengene Therapeutics Limited and the Registrant (Filed With SEC on August 4, 2020)
- License Agreement, dated May 23, 2018, by and between Antengene Therapeutics Limited and the Registrant (Filed With SEC on August 7, 2018)
- License Agreement, dated October 11, 2017, by and between the Registrant and Ono Pharmaceutical Co., Ltd (Filed With SEC on March 15, 2018)
